Companies: 10,795·Total market cap: $144.5T
Arbutus Biopharma Corporation

Arbutus Biopharma Corporation

ABUSNASDAQHealthcare● Active
$4.22
$-0.03(-0.78%)
Market Cap$833016523
P/E Ratio
52W High$5.1
52W Low$3.04

Arbutus Biopharma Corporation (ABUS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ABUS · as of Mar 23, 2026

Latest filing snapshot

19
-25-56.82%vs prior year

Arbutus Biopharma Corporation (ABUS) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
19
Change (1Y)
-25
Growth % (1Y)
-56.82%
Revenue / Employee
$741.2K
Net Income / Employee
$-1.76M
Market Cap
$833M

ABUS Employee Count

2010 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-2319-25-56.82%
2025-03-2744-29-39.73%
2024-03-0573-25-25.51%
2023-03-0298+11+12.64%
2022-03-0387+9+11.54%
2021-03-0478-2-2.50%
2020-03-0580+0+0.00%
2019-03-0780-50-38.46%
2018-03-16130+8+6.56%
2017-03-22122-12-8.96%

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
ProKidney Corp.
PROK
ProKidney Corp.
204
#2
Kura Oncology, Inc.
KURA
Kura Oncology, Inc.
192
#3
EyePoint Pharmaceuticals, Inc.
EYPT
EyePoint Pharmaceuticals, Inc.
165
#4
Nanobiotix S.A.
NBTX
Nanobiotix S.A.
108
#5
Bicara Therapeutics Inc. Common Stock
BCAX
Bicara Therapeutics Inc. Common Stock
55
#6
GH Research PLC
GHRS
GH Research PLC
50
#7
Arbutus Biopharma Corporation
ABUS
Arbutus Biopharma CorporationYOU
19
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ABUS peer comparison

About ABUS employees

ABUS Employees · Headcount

Arbutus Biopharma Corporation (ABUS) employee data is sourced from the annual SEC 10-K filing. As of 2025, Arbutus Biopharma Corporation had 19 full-time employees globally. Full-time employees only. Global consolidated headcount.

Arbutus Biopharma Corporation employs 19 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $741,211, reflecting the company's operational efficiency.

Arbutus Biopharma Corporation's workforce decreased by 25 (56.82%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Arbutus Biopharma Corporation's revenue per employee of $741,211 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

ABUS Employees · 5 questions

As of the latest SEC 10-K filing (2025), Arbutus Biopharma Corporation had 19 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Arbutus Biopharma Corporation employee counthow many employees does Arbutus Biopharma Corporation haveABUS total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-23